BioAge Labs, Inc. Common Stock
Symbol: BIOA (NASDAQ)
4.86
▲ (0.73%) 0.035
Company Description:
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
Key Stats
- Today's Open: $4.8
- Today's High: $4.858
- Today's Low: $4.811
- Today's Volume: 11.99K
- Yesterday Close: $4.82
- Yesterday High: $5.075
- Yesterday Low: $4.82
- Yesterday Volume: 154.44K
- Last Min Volume: 15
- Last Min High: $4.855
- Last Min Low: $4.838
- Last Min VWAP: $4.84873
Company Profile
- Name: BioAge Labs, Inc. Common Stock
- Website: https://www.bioagelabs.com
- Listed Date: 2024-09-26
- Location: EMERYVILLE, CA
- Market Status: Active
- CIK Number: 0001709941
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $172.80M
- Round Lot: 100
- Outstanding Shares: 35.85M
- Asset Type: CS
RECENT FILINGS FOR BIOA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-11 | 4 | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 8-K | View |
| 2025-06-04 | 8-K | View |
| 2025-05-06 | 10-Q | View |
| 2025-05-06 | 8-K | View |
| 2025-04-17 | ARS | View |
| 2025-04-17 | DEFA14A | View |
| 2025-04-17 | DEF 14A | View |
| 2025-03-20 | S-8 | View |
| 2025-03-20 | 10-K | View |
| 2025-03-20 | 8-K | View |
Latest News on BIOA